Centre proposes immediate suspension of licences for substandard drugs
Times of India
The Health Ministry has introduced new regulations aimed at suspending
manufacturing licenses for medicines that do not meet quality criteria. This
swift action is intended to stop subpar drugs from reaching patients and to
minimize their circulation during the regulatory review. Licenses can be
suspended based on government analysts' findings that indicate deficiencies.





